Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life

Journal of Pain and Symptom Management

Volumn 13, Issue 5, 1997, Pages 254-261

  Ahmedzai, Sam ^a   Brooks, David ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

administration, cutaneous; drug therapy; fentanyl; morphine; opioid analgesics; Pain; palliative treatment; patient satisfaction; quality of life

Indexed keywords

FENTANYL; MORPHINE SULFATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030909704     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00082-1     Document Type: Letter

References (13)

1. Larue F, Colleau SM, Brasseur L, Cleeland CS, Multicentre study of cancer pain and its treatment in France. BMJ 1995;310:1034-1037.
2. Ahmedzai S. Recent clinical trials of pain control: impact on quality of life. Eur J Cancer 1995;3/A Suppl 6:S2-S7.
3. Saunders C, Baines M. Living with dying. The management of terminal disease. Oxford: Oxford University Press, 1983.
4. TTS-fentanyl multicentre study group. Transdermal fentanyl in cancer pain. J Drug Dev 1994;6: 93-97.
5. Zech D, Grond S, Breitenbach H, Hertel D. Transdermal fentanyl in the treatment of tumour pain. A prospective study in 42 patients with malignant disease. Pain 1992;50:293-301.
6. ABPI data sheet compendium 1995-96. London: Datapharm, 1995:724-726.
7. World Health Organization (WHO) handbook for reporting results of cancer treatment (Geneva offset publication vol 48). Geneva: WHO, 1979:7-33.
8. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
9. Fishman B, Pasternak S, Wallenstein SL. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987;60: 1151-1157.
10. Higgs C, Vella-Brincat J. Withdrawal with transdermal fentanyl. J Pain Symptom Manage 1995;10:4-5.
11. Zenz M, Donner B, Strumpf M. Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)? J Pain Symptom Manage 1994;9:54-55.
12. de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;10: 378-384.
13. Donner B, Zenz M, Tryba M, Strumpf M. Director conversion from oral morphine to transdermal fentanyl: a multicentre study in patients with cancer pain. Pain 1996;64:527-534.